Falcasantos, Aldren E.
HRN: 09-80-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/05/2022
11/11/2022
PO
10 ML
TID
AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes